Notícias

(Bloomberg) -- Oklo Inc.’s small modular reactor has reached a key milestone, the Energy Department announced Thursday.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftMicrosoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowMajor Hedge Funds Targeted in Wave of Attempted CyberattacksWhy Do Data Centers Use So Much Fresh Water?Oklo’s Groves Isotope Test Reactor in Texas reached “criticality,” which occur

As OKLO gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

A positive update on Oklo's reactor progress could reverse the nuclear stock's downward spiral.

Shares of Oklo have fallen close to 40% this year.

From Berkshire Hathaway to Oklo, there are plenty of ways to construct a diversified energy portfolio with $10,000.

Earnings continue to be the market's engine, and a series of results this week from Palantir, SpaceX, and AMD are set to rev up stocks again.

As SMR gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

Oklo could survive an AI bust, but its valuation probably couldn't.

Oklo stock has delivered a very large 5 year gain, yet the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. Oklo has returned 291.8% over 5 years, which makes the recent share price level look demanding for new investors who focus on entry price. The recent U.S. Department of Energy authorization for the Groves isotope reactor can support expectations for commercial isotope revenue. At the same time, execution and regulatory risk around scaling...

Constellation Energy, Constellation Energy stock, CEG stock, nuclear stocks, best nuclear stock

One sells power today with $2B in revenue and major partnerships; the other has zero revenue but billion-dollar customer commitments.

The uranium fund's history of deep dives offers a tough lesson for anyone tempted by the current discount.

The Microsoft co-founder is betting billions on the future of nuclear power.

Advanced nuclear fission developer Oklo (OKLO) reached a major regulatory milestone after receiving official startup authorization from the U.S. Department of Energy (DOE) for its Groves Isotope Test Reactor in Lockhart, Texas. Key Takeaways Oklo received formal U.S. Department of Energy (DOE) authorization to load nuclear fuel and begin startup testing at its Groves reactor [...]

AI-driven power demand puts Bloom Energy's commercial scale against OKLO's advanced nuclear ambitions in a high-stakes clean energy comparison.

There's a reason the hype around these two nuclear technology stocks is fading.

Oklo has plunged from last year's highs, but its progress and leadership could make it a compelling buy.

One is pre-revenue with zero debt; the other generates $710 million in sales but burns cash faster.

Oklo remains a very risky way to play the nuclear power resurgence.

US-Saudi nuclear deal could reshape the energy landscape. See how nuclear ETFs may offer diversified exposure to companies positioned to benefit.

Oklo (NYSE:OKLO) received startup authorization from the U.S. Department of Energy for its Groves Isotope Test Reactor. The approval completes a key regulatory process and allows Oklo to begin fuel loading, startup testing, and reactor operations. Oklo focuses on advanced nuclear reactors and related services, with the Groves Isotope Test Reactor positioned to support production of high value isotopes for multiple industries. For investors watching the nuclear space, this milestone...

Investors shifted away from capital-intensive AI and clean-energy stocks amid profitability concerns.

Nuclear growth could accelerate as AI demand, smaller reactors, faster licensing and fuel supply gains advance NNE, OKLO and SMR.

Oklo stock might be on the rise.

The fast track is even faster than investors expected.

The stock is now down 75% from all-time highs.

A $2,000 investment in Oklo today could be worth more a year from now, but it may not be the windfall some investors would hope for.

SMR's regulatory lead and $1 billion liquidity set the stage, but contracts, financing and dilution will decide its commercial success.

NuScale's valuation has reset, but its buy case still hinges on turning approved technology and project pipelines into contracts, financing and revenues.

OKLO secured DOE startup authorization for its Groves test reactor, clearing fuel loading and testing toward first criticality and isotope production.